GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.42X leverage
Performance
- Low
- ₹2,009
- High
- ₹2,042
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,025
- Previous Close₹2,008
- Volume343,424
- 50 DMA₹1,980.33
- 100 DMA₹1,939.56
- 200 DMA₹1,840.15
Investment Returns
- Over 1 Month + 3.12%
- Over 3 Month + 6.66%
- Over 6 Month -6.62%
- Over 1 Year + 36.06%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.3
- PEG Ratio
- 0.3
- Market Cap Cr
- 56,832
- P/B Ratio
- 5.9
- Average True Range
- 49.49
- EPS
- 89.11
- Dividend Yield
- 0.2
- MACD Signal
- 30.14
- RSI
- 49.99
- MFI
- 59.38
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,013.90
+
5.7
(0.28%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹2,020.65
- 50 Day
- ₹1,980.33
- 100 Day
- ₹1,939.56
- 200 Day
- ₹1,840.15
Resistance and Support
1995.77
- R3 2,117.33
- R2 2,072.67
- R1 2,040.43
- S1 1,963.53
- S2 1,918.87
- S3 1,886.63
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,013 As on 14 January, 2026 | 12:00
The Market Cap of Glenmark Pharmaceuticals is ₹56832.4 Cr As on 14 January, 2026 | 12:00
The P/E ratio of Glenmark Pharmaceuticals is 56.3 As on 14 January, 2026 | 12:00
The PB ratio of Glenmark Pharmaceuticals is 5.9 As on 14 January, 2026 | 12:00
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.